# Research and Markets: Practical Biostatistics

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/9xx9v9/practical) has announced the addition of Elsevier Science and Technology's new book "Practical Biostatistics" to their offering.

Evidence-based medicine aims to apply the best available evidence gained from the scientific method to medical decision making. It is a practice that uses statistical analysis of scientific methods and outcomes to drive further experimentation and diagnosis. The profusion of evidence-based medicine in medical practice and clinical research has produced a need for life scientists and clinical researchers to assimilate biostatistics into their work to meet efficacy and practical standards. Practical Biostatistics provides researchers, medical professionals, and students with a friendly, practical guide to biostatistics. With a detailed outline of implementation steps complemented by a review of important topics, this book can be used as a quick reference or a hands-on guide to effectively incorporate biostatistics in clinical trials.

Key Features:

- Customized presentation for biological investigators with examples taken from current clinical trials in multiple disciplines

- Clear and concise definitions and examples provide a pragmatic guide to bring clarity to the applications of statistics in improving human health

- Addresses the challenge of assimilation of mathematical concepts to better interpret literature, to build stronger studies, to present research effectively, and to improve communication with supporting biostatisticians

Topics Covered:

PART 1

STUDY TYPE DETERMINATION

1. Epidemiological studies

2. Analytical studies

3. Summary

PART 2

OBSERVATIONAL STUDIES

4. Determination of association strength between an exposure factor and an event in observational studies

5. Increasing accuracy in observational studies

PART 3

STEP-BY-STEP BIOSTATISTICS OF A CLINICAL TRIAL

6. STEP 1: Investigator's hypothesis and expression of its corresponding outcome

7. STEP 2: n estimation and n assessment of a published trial

8. STEP 3: Organization of variables and endpoints

9. STEP 4: Measures for results expression of a clinical trial

10. STEP 5: Determination of normality or non-normality of data distribution

11. STEP 6: Hypothesis testing

12. STEP 7: Correlating sample data with the general population 95% confidence Interval

PART 4

ADDITIONAL CONCEPTS IN BIOSTATISTICS

13. Individual and collective benefit and risk indexes inferable from intervention cohort studies

14. Statistical assessment of diagnostic tests for the clinic

15. Systematic reviews and meta-analyses

16. Correlation and regression

17. Per protocol analysis and intention to treat analysis

Self-evaluation Annotated answers Microsoft Excel 2010

Basics References

Glossary

Index

Authors

Suchmacher, Mendel

Geller, Mauro

For more information visit http://www.researchandmarkets.com/research/9xx9v9/practical

Source: Elsevier Science and Technology

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology, Mathematics

View Comments and Join the Discussion!

 1 HUM, AET: The Fate Of Humana Rests In The Hands Of A Federal Judge 2 LLY, SMSI: 18 Stocks Moving In Wednesday's Pre-Market Session 3 MS: The Strip And The Street: A Conversation With Mathematician,... 4 NTNX: Nutanix Could Move 25% Higher As Management Goes Hunting... 5 GLD, GDX: Donald Trump: U.S. Dollar Is 'Too Strong' 6 FNMA, FMCC: Keep An Eye On Fannie And Freddie Tomorrow 7 SPLK: Splunk Has A 'Clear Path'...
 1 NFLX, AMZN: Video Streaming Surpasses DVD/Blu-Ray Sales For The First Time 2 GBP/USD Trading Higher, RICS Downgrades U.K Home Sales 3 VNOM, CHKP: 20 Stocks Moving In Thursday's Pre-Market Session 4 TSLA: The 'Tesla Killer' Is In Shambles 5 NFLX: Netflix's Studio Margins Will Be Eliminated, Th... 6 EUR/USD Little Higher, ECB Leaves Rate at Zero percent 7 CHKP, KEY: A Peek Into The Markets: U.S. Stock Futures...